{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:50:12Z","timestamp":1790628612617,"version":"4.1.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.oftale.2026.502549","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:04:47Z","timestamp":1776384287000},"page":"502549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Melatonin and glaucoma: Current insights and clinical prospectives"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3725-8211","authenticated-orcid":false,"given":"A.","family":"Martucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6479-1807","authenticated-orcid":false,"given":"F.","family":"Aiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Mancino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cesareo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Nucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oftale.2026.502549_bib0005","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/ceo.14040","article-title":"Primary glaucomas in adults: epidemiology and public health\u2014a review","volume":"50","author":"Reis","year":"2022","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.oftale.2026.502549_bib0010","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.oftale.2026.502549_bib0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4103\/1673-5374.244781","article-title":"Evidence on neuroprotective properties of coenzyme Q10 in the treatment of glaucoma","volume":"14","author":"Martucci","year":"2019","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.oftale.2026.502549_bib0020","article-title":"Editorial: new perspectives in glaucoma pathophysiology, diagnosis, and treatment","volume":"10","author":"Martucci","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.oftale.2026.502549_bib0025","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14176145","article-title":"Next-gen neuroprotection in glaucoma: synergistic molecules for targeted therapy","volume":"14","author":"Martucci","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.oftale.2026.502549_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1724780","article-title":"Reduced retinal microvascular density in patients with mixed connective tissue disease: an exploratory pilot study on the interplay between aging, renal function, and complement system","volume":"17","author":"Triggianese","year":"2026","journal-title":"Front Immunol"},{"key":"10.1016\/j.oftale.2026.502549_bib0035","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41420-025-02824-y","article-title":"Metformin protects retinal ganglion cells in a preclinical model of retinal ischemia\/reperfusion injury and stabilizes visual field in diabetic patients with glaucoma","volume":"11","author":"Satriano","year":"2025","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.oftale.2026.502549_bib0040","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archopht.121.1.48","article-title":"Factors for glaucoma progression and the effect of treatment","volume":"121","author":"Leske","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"10.1016\/j.oftale.2026.502549_bib0045","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12092000","article-title":"Glaucoma: Current and new therapeutic approaches","volume":"12","author":"Lee","year":"2024","journal-title":"Biomedicines"},{"issue":"S279","key":"10.1016\/j.oftale.2026.502549_bib0050","doi-asserted-by":"crossref","DOI":"10.1111\/aos.16419","article-title":"Combined use of neuroprotective agents: a new treatment strategy for patients with glaucoma","volume":"102","author":"Martucci","year":"2024","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oftale.2026.502549_bib0055","article-title":"Editorial: update on glaucoma research: from basic science to clinical practice","volume":"12","author":"Martucci","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.oftale.2026.502549_bib0060","first-page":"938","article-title":"Neuroprotective agents in the management of glaucoma","volume":"32","author":"Nucci","year":"2018","journal-title":"Eye (Basingstoke)"},{"key":"10.1016\/j.oftale.2026.502549_bib0065","article-title":"Combined use of coenzyme Q10 and citicoline: a new possibility for patients with glaucoma","volume":"9","author":"Martucci","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.oftale.2026.502549_bib0070","doi-asserted-by":"crossref","DOI":"10.3390\/ma14123197","article-title":"Non-ionic surfactants for stabilization of polymeric nanoparticles for biomedical uses","volume":"14","author":"Cort\u00e9s","year":"2021","journal-title":"Materials"},{"key":"10.1016\/j.oftale.2026.502549_bib0075","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/bs.pbr.2020.07.007","article-title":"Brain networks reorganization and functional disability in glaucoma","volume":"257","author":"Martucci","year":"2020","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.oftale.2026.502549_bib0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914932","article-title":"MRI and clinical biomarkers overlap between glaucoma and Alzheimer\u2019s disease","volume":"24","author":"Martucci","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.oftale.2026.502549_bib0085","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.coph.2021.12.003","article-title":"Imaging biomarkers for Alzheimer\u2019s disease and glaucoma: current and future practices","volume":"62","author":"Martucci","year":"2022","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.oftale.2026.502549_bib0090","series-title":"Proceedings of the 41st Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBS)","article-title":"Disruption of brain network organization in primary open angle glaucoma","author":"Minosse","year":"2019"},{"key":"10.1016\/j.oftale.2026.502549_bib0095","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.01134","article-title":"Primary open angle glaucoma is associated with functional brain network reorganization","volume":"10","author":"Minosse","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.oftale.2026.502549_bib0100","series-title":"Proceedings of the 42nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBS)","article-title":"Disruption of structural brain networks in primary open angle glaucoma","author":"Di Ci\u00f2","year":"2020"},{"key":"10.1016\/j.oftale.2026.502549_bib0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2020.102419","article-title":"Reorganization of the structural connectome in primary open angle Glaucoma","volume":"28","author":"Di Ci\u00f2","year":"2020","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.oftale.2026.502549_bib0110","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9103122","article-title":"Diffusional kurtosis imaging of white matter degeneration in glaucoma","volume":"9","author":"Nucci","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.oftale.2026.502549_bib0115","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.coph.2012.08.004","article-title":"Brain involvement in glaucoma: advanced neuroimaging for understanding and monitoring a new target for therapy","volume":"13","author":"Nucci","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.oftale.2026.502549_bib0120","first-page":"73","article-title":"Neurodegeneration and neuroprotection in glaucoma","volume":"89","author":"Gauthier","year":"2016","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.oftale.2026.502549_bib0125","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/ICU.0b013e3280895aea","article-title":"Glaucoma as a neurodegenerative disease","volume":"18","author":"Gupta","year":"2007","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.oftale.2026.502549_bib0130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/EB.S293765","article-title":"Glaucoma as neurodegeneration in the brain","volume":"13","author":"Chan","year":"2021","journal-title":"Eye Brain"},{"key":"10.1016\/j.oftale.2026.502549_bib0135","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.2174\/0929867325666180307114332","article-title":"Neurodegenerative process linking the eye and the brain","volume":"26","author":"Mancino","year":"2019","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.oftale.2026.502549_bib0140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10792-012-9623-4","article-title":"Glaucoma progression associated with Leber\u2019s hereditary optic neuropathy","volume":"33","author":"Nucci","year":"2013","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.oftale.2026.502549_bib0145","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1442-9071.2010.02452.x","article-title":"Glaucoma progression associated with altered cerebral spinal fluid levels of amyloid beta and tau proteins","volume":"39","author":"Nucci","year":"2011","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.oftale.2026.502549_bib0150","first-page":"397","article-title":"Common sleep disorders in adults: diagnosis and management","volume":"105","author":"Holder","year":"2022","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.oftale.2026.502549_bib0155","first-page":"150","article-title":"Glaucoma-related sleep disorder and associated diseases","volume":"236","author":"Weissleder","year":"2019","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.oftale.2026.502549_bib0160","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5005\/jp-journals-10078-1301","article-title":"Prevalence of obstructive sleep apnea in glaucoma patients: a systematic review and meta-analysis","volume":"15","author":"Yu","year":"2022","journal-title":"J Curr Glaucoma Pract"},{"key":"10.1016\/j.oftale.2026.502549_bib0165","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.2147\/OPTH.S387623","article-title":"Association of glaucoma with poor quality of sleep in an Ethiopian glaucoma population \u2013 a comparative cross-sectional study","volume":"16","author":"Tegegne","year":"2022","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.oftale.2026.502549_bib0170","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jcjo.2022.02.010","article-title":"Anxiety, depression, and sleep-related outcomes of glaucoma patients: systematic review and meta-analysis","volume":"58","author":"Groff","year":"2023","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.oftale.2026.502549_bib0175","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-063676","article-title":"Association of sleep behaviour and pattern with the risk of glaucoma: a prospective cohort study in the UK Biobank","volume":"12","author":"Sun","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.oftale.2026.502549_bib0180","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40662-025-00436-2","article-title":"Sleep duration modifies the association between obstructive sleep apnea risk and glaucoma: evidence from the Korea National Health and Nutrition Examination Survey","volume":"12","author":"Kwak","year":"2025","journal-title":"Eye Vis"},{"key":"10.1016\/j.oftale.2026.502549_bib0185","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/NSS.S439274","article-title":"Investigating the causal relationship between sleep behaviors and primary open-angle glaucoma: a bidirectional two-sample Mendelian randomization study","volume":"16","author":"Zhang","year":"2024","journal-title":"Nat Sci Sleep"},{"key":"10.1016\/j.oftale.2026.502549_bib0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/bs.pbr.2020.07.010","article-title":"Links between obstructive sleep apnea and glaucoma neurodegeneration","volume":"257","author":"Cesareo","year":"2020","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.oftale.2026.502549_bib0195","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12662","article-title":"Decreased melatonin secretion in patients with glaucoma: quantitative association with glaucoma severity in the LIGHT study","volume":"69","author":"Yoshikawa","year":"2020","journal-title":"J Pineal Res"},{"key":"10.1016\/j.oftale.2026.502549_bib0200","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.exer.2006.10.018","article-title":"Melatonin in the eye: implications for glaucoma","volume":"84","author":"Lundmark","year":"2007","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.oftale.2026.502549_bib0205","first-page":"1337","article-title":"Melatonin concentrations in serum of primary glaucoma patients","volume":"11","author":"Ma","year":"2018","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.oftale.2026.502549_bib0210","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1007\/s10571-023-01324-w","article-title":"Melatonin and health: insights of melatonin action, biological functions, and associated disorders","volume":"43","author":"Ahmad","year":"2023","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.oftale.2026.502549_bib0215","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-079X.2011.00880.x","article-title":"Dynamics in enzymatic protein complexes offer a novel principle for the regulation of melatonin synthesis in the human pineal gland","volume":"51","author":"Maronde","year":"2011","journal-title":"J Pineal Res"},{"key":"10.1016\/j.oftale.2026.502549_bib0220","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.exer.2012.08.009","article-title":"Melatonin: an underappreciated player in retinal physiology and pathophysiology","volume":"103","author":"Tosini","year":"2012","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.oftale.2026.502549_bib0225","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1177\/002215540205000408","article-title":"Distribution of melatonin MT1 receptor immunoreactivity in human retina","volume":"50","author":"Savaskan","year":"2002","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.oftale.2026.502549_bib0230","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/156720507779939823","article-title":"The MT2 melatonin receptor subtype is present in human retina and decreases in Alzheimers disease","volume":"4","author":"Savaskan","year":"2007","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.oftale.2026.502549_bib0235","first-page":"1","article-title":"Melatonin as a therapeutic tool in ophthalmology: implications for glaucoma and uveitis","volume":"49","author":"Rosenstein","year":"2010","journal-title":"J Pineal Res"},{"key":"10.1016\/j.oftale.2026.502549_bib0240","doi-asserted-by":"crossref","first-page":"256","DOI":"10.32794\/mr112500154","article-title":"Effects of melatonin on the circadian functions of sleep-wake cycle, metabolism, hormonal regulation and immune activity: a recent review","volume":"6","author":"Sarisozen","year":"2023","journal-title":"Melatonin Res"},{"key":"10.1016\/j.oftale.2026.502549_bib0245","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13048-024-01512-2","article-title":"Melatonin increases superoxide dismutase 2 (SOD2) levels and improves rat ovarian graft function after transplantation","volume":"17","author":"Monteiro","year":"2024","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.oftale.2026.502549_bib0250","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/IJG.0000000000001402","article-title":"Circadian rhythm and glaucoma: what do we know?","volume":"29","author":"Ciulla","year":"2020","journal-title":"J Glaucoma"},{"key":"10.1016\/j.oftale.2026.502549_bib0255","first-page":"1163","article-title":"ipRGCs: possible causation accounts for the higher prevalence of sleep disorders in glaucoma patients","volume":"10","author":"Guo","year":"2017","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.oftale.2026.502549_bib0260","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.chembiol.2023.08.014","article-title":"Metabolic and chemical architecture of the mammalian circadian clock","volume":"30","author":"Laothamatas","year":"2023","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.oftale.2026.502549_bib0265","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00018-020-03641-5","article-title":"Diversity of intrinsically photosensitive retinal ganglion cells: circuits and functions","volume":"78","author":"Aranda","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.oftale.2026.502549_bib0270","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.636330","article-title":"Intrinsically photosensitive retinal ganglion cells of the human retina","volume":"12","author":"Mure","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.oftale.2026.502549_bib0275","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1523\/JNEUROSCI.0674-20.2020","article-title":"Photoreceptive ganglion cells Drive circuits for local inhibition in the mouse retina","volume":"41","author":"Pottackal","year":"2021","journal-title":"J Neurosci"},{"key":"10.1016\/j.oftale.2026.502549_bib0280","doi-asserted-by":"crossref","DOI":"10.31083\/j.fbl2912410","article-title":"Circadian disruption in glaucoma: causes, consequences, and countermeasures","volume":"29","author":"Gubin","year":"2024","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.oftale.2026.502549_bib0285","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1167\/iovs.16-19997","article-title":"Loss of melanopsin-expressing retinal ganglion cells in severely staged glaucoma patients","volume":"57","author":"Obara","year":"2016","journal-title":"Invest Opthalmol Vis Sci"},{"key":"10.1016\/j.oftale.2026.502549_bib0290","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1167\/iovs.10-7069","article-title":"Intrinsically photosensitive (Melanopsin) retinal ganglion cell function in glaucoma","volume":"52","author":"Feigl","year":"2011","journal-title":"Invest Opthalmol Vis Sci"},{"key":"10.1016\/j.oftale.2026.502549_bib0295","first-page":"1299","article-title":"Melanopsin-expressing retinal ganglion cells in aging and disease","volume":"34","author":"Esquiva","year":"2019","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.oftale.2026.502549_bib0300","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1080\/07420528.2021.1931275","article-title":"Seasonal variation in neurohormones, mood and sleep in patients with primary open angle glaucoma \u2013 implications of the ipRGC-system","volume":"38","author":"\u00d8stergaard Madsen","year":"2021","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.oftale.2026.502549_bib0305","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s10792-014-9920-1","article-title":"Evaluation of pupillary response to light in patients with glaucoma: a study using computerized pupillometry","volume":"34","author":"Martucci","year":"2014","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.oftale.2026.502549_bib0310","article-title":"The neuroprotective effect of melatonin in glutamate excitotoxicity of R28 cells and mouse retinal ganglion cells","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.oftale.2026.502549_bib0315","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13051213","article-title":"Melatonin in glaucoma: integrative mechanisms of intraocular pressure control and neuroprotection","volume":"13","author":"Hou","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.oftale.2026.502549_bib0320","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12828","article-title":"Anti\u2010PANoptosis is involved in neuroprotective effects of melatonin in acute ocular hypertension model","volume":"73","author":"Ye","year":"2022","journal-title":"J Pineal Res"},{"key":"10.1016\/j.oftale.2026.502549_bib0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109976","article-title":"Melatonin protects against NMDA-induced retinal ganglion cell injury by regulating the microglia-TNF\u03b1-RGC p38 MAPK pathway","volume":"118","author":"Zou","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.oftale.2026.502549_bib0330","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70074","article-title":"Melatonin regulates mitochondrial dynamics and mitophagy: cardiovascular protection","volume":"28","author":"Rahmani","year":"2024","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.oftale.2026.502549_bib0335","article-title":"The potential influence of melatonin on mitochondrial quality control: a review","volume":"14","author":"Lei","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.oftale.2026.502549_bib0340","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neulet.2011.02.056","article-title":"Removal of melatonin receptor type 1 increases intraocular pressure and retinal ganglion cells death in the mouse","volume":"494","author":"Alcantara-Contreras","year":"2011","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.oftale.2026.502549_bib0345","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1124\/jpet.114.218263","article-title":"Melatonin receptors trigger cAMP production and inhibit chloride movements in nonpigmented ciliary epithelial cells","volume":"352","author":"Huete-Toral","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.oftale.2026.502549_bib0350","article-title":"Regulation of aqueous humor secretion by melatonin in porcine ciliary epithelium","volume":"24","author":"Li","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.oftale.2026.502549_bib0355","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.pharmthera.2006.11.003","article-title":"Melatonin receptors in the eye: location, second messengers and role in ocular physiology","volume":"113","author":"Alarma-Estrany","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.oftale.2026.502549_bib0360","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.exer.2016.08.023","article-title":"Role of the Rho GTPase\/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: bench to bedside research","volume":"158","author":"Rao","year":"2017","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.oftale.2026.502549_bib0365","first-page":"530","article-title":"Changes in melatonin receptor expression in a murine model of glaucoma","volume":"26","author":"Mart\u00ednez-\u00c1guila","year":"2020","journal-title":"Mol Vis"},{"key":"10.1016\/j.oftale.2026.502549_bib0370","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1038\/s41433-024-03358-w","article-title":"Melatonin as an adjuvant: reshaping glaucoma treatment strategies","volume":"38","author":"Ali","year":"2024","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.oftale.2026.502549_bib0375","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12730","article-title":"Melatonin mitigates disrupted circadian rhythms, lowers intraocular pressure, and improves retinal ganglion cells function in glaucoma","volume":"70","author":"Gubin","year":"2021","journal-title":"J Pineal Res"},{"key":"10.1016\/j.oftale.2026.502549_bib0380","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5318\/wjo.v3.i4.32","article-title":"Melatonin and derivatives as promising tools for glaucoma treatment","volume":"3","author":"Alkozi","year":"2013","journal-title":"World J Ophthalmol"},{"key":"10.1016\/j.oftale.2026.502549_bib0385","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1124\/jpet.115.231456","article-title":"Effect of melatonin and 5-methoxycarbonylamino-N-acetyltryptamine on the intraocular pressure of normal and glaucomatous mice","volume":"357","author":"Mart\u00ednez-\u00c1guila","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.oftale.2026.502549_bib0390","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1124\/jpet.112.202036","article-title":"Melatonin and its analog 5-methoxycarbonylamino-N-acetyltryptamine potentiate adrenergic receptor-mediated ocular hypotensive effects in rabbits: significance for combination therapy in glaucoma","volume":"346","author":"Crooke","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"issue":"1-3","key":"10.1016\/j.oftale.2026.502549_bib0395","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejphar.2012.12.009","article-title":"Melatonin analogue agomelatine reduces rabbit\u2019s intraocular pressure in normotensive and hypertensive conditions","volume":"701","author":"Mart\u00ednez-\u00c1guila","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.oftale.2026.502549_bib0400","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/ph17040441","article-title":"The therapeutic trip of melatonin eye drops: from the ocular surface to the retina","volume":"17","author":"Rusciano","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.oftale.2026.502549_bib0405","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00228-015-1873-4","article-title":"Clinical pharmacokinetics of melatonin: a systematic review","volume":"71","author":"Harps\u00f8e","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.oftale.2026.502549_bib0410","doi-asserted-by":"crossref","DOI":"10.3390\/biom13060943","article-title":"Melatonin: facts, extrapolations and clinical trials","volume":"13","author":"Boutin","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.oftale.2026.502549_bib0415","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25073999","article-title":"A clinical, pharmacological, and formulation evaluation of melatonin in the treatment of ocular disorders\u2014a systematic review","volume":"25","author":"Romeo","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.oftale.2026.502549_bib0420","doi-asserted-by":"crossref","DOI":"10.3390\/nu11030527","article-title":"Bioavailability and sustained plasma concentrations of CoQ10 in healthy volunteers by a novel oral timed-release preparation","volume":"11","author":"Martucci","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.oftale.2026.502549_bib0425","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics10030138","article-title":"Hypotensive effect of nanomicellar formulation of melatonin and agomelatine in a rat model: significance for glaucoma therapy","volume":"10","author":"Dal Monte","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.oftale.2026.502549_bib0430","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14051019","article-title":"Melatonin-eluting contact lenses effect on tear volume: in vitro and in vivo experiments","volume":"14","author":"Serramito","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.oftale.2026.502549_bib0435","doi-asserted-by":"crossref","first-page":"10902","DOI":"10.1039\/D4TB00745J","article-title":"Near-infrared activated liposomes for neuroprotection in glaucoma","volume":"12","author":"Matuwana","year":"2024","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.oftale.2026.502549_bib0440","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40261-015-0368-5","article-title":"The safety of melatonin in humans","volume":"36","author":"Andersen","year":"2016","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.oftale.2026.502549_bib0445","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00004714-200104000-00008","article-title":"Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin","volume":"21","author":"H\u00e4rtter","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.oftale.2026.502549_bib0450","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s002280000245","article-title":"Cytochrome P 450 isoforms involved in melatonin metabolism in human liver microsomes","volume":"56","author":"Facciol\u00e1","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.oftale.2026.502549_bib0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120866","article-title":"Melatonin effect on platelets and coagulation: implications for a prophylactic indication in COVID-19","volume":"307","author":"Hosseinzadeh","year":"2022","journal-title":"Life Sci"},{"key":"10.1016\/j.oftale.2026.502549_bib0460","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5152\/eurasianjmed.2015.0267","article-title":"A review of melatonin, its receptors and drugs","volume":"48","author":"Emet","year":"2019","journal-title":"Eurasian J Med"},{"key":"10.1016\/j.oftale.2026.502549_bib0465","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1080\/10717544.2020.1818882","article-title":"Intravitreous delivery of melatonin affects the retinal neuron survival and visual signal transmission: in vivo and ex vivo study","volume":"27","author":"Tao","year":"2020","journal-title":"Drug Deliv"},{"key":"10.1016\/j.oftale.2026.502549_bib0470","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1213\/ane.0b013e3181907ebe","article-title":"Melatonin provides anxiolysis, enhances analgesia, decreases intraocular pressure, and promotes better operating conditions during cataract surgery under topical anesthesia","volume":"108","author":"Ismail","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1016\/j.oftale.2026.502549_bib0475","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-079X.2011.00938.x","article-title":"Involvement of carbonic anhydrases in the ocular hypotensive effect of melatonin analogue 5-MCA-NAT","volume":"52","author":"Crooke","year":"2012","journal-title":"J Pineal Res"},{"key":"10.1016\/j.oftale.2026.502549_bib0480","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/opo.12189","article-title":"Oral treatment with the melatonin agonist agomelatine lowers the intraocular pressure of glaucoma patients","volume":"35","author":"Pescosolido","year":"2015","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.oftale.2026.502549_bib0485","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239267","article-title":"A topical formulation of melatoninergic compounds exerts strong hypotensive and neuroprotective effects in a rat model of hypertensive glaucoma","volume":"21","author":"Dal Monte","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.oftale.2026.502549_bib0490","article-title":"Effects of melatonin supplementation on sleep quality in patients with advanced glaucoma: a randomized, double-masked, placebo-controlled crossover trial","author":"Nogueira","year":"2025","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.oftale.2026.502549_bib0500","series-title":"Melatonin: adverse effects and drug interactions","author":"Savage","year":"2025"}],"container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173579426001015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173579426001015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T02:43:14Z","timestamp":1780281794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173579426001015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":99,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2173579426001015"],"URL":"https:\/\/doi.org\/10.1016\/j.oftale.2026.502549","relation":{},"ISSN":["2173-5794"],"issn-type":[{"value":"2173-5794","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melatonin and glaucoma: Current insights and clinical prospectives","name":"articletitle","label":"Article Title"},{"value":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oftale.2026.502549","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.oftal.2026.502549","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Oftalmolog\u00eda. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"502549"}}